BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 28, 2007
View Archived Issues
Recent findings from antimalarial, antiviral research
Read More
Recent Novartis patents describe novel therapeutic agents for hepatitis
Read More
Recent patents describe novel therapeutic agents for infectious diseases
Read More
Eisai presents semiannual results for fiscal year ending March 31, 2008
Read More
Novel analgesic agents reported in recent patent literature
Read More
Positive clinical data for milnacipran in fibromyalgia syndrome treatment
Read More
Studies show pitrakinra improves late asthmatic response after allergen challenge
Read More
BAY-639044 evaluated in first-in-man study
Read More
Argenta and Dr. Reddy's select preclinical candidate for respiratory diseases
Read More
InterMune buys out license agreement for pirfenidone from Marnac and KDL
Read More
CytRx reports positive safety and tolerability results from clinical trial of arimoclomol
Read More
NovaBay reports positive results from phase I clinical trial of AgaNase
Read More
Antiarthritic efficacy of novel dual-variable-domain anti-IL-1alpha/IL-1beta immunoglobulins
Read More
GlaxoSmithKline obtains exclusive U.S. OTC marketing rights to Mevacor
Read More
Positive results reported in dose-escalation safety study with pramiconazole
Read More
Safety analysis completed in first patient cohort from Nventa's HspE7 trial
Read More
Sosei presents update on SD-118 neuropathic pain program
Read More
QRxPharma initiates phase III clinical trial of Q-8003-IR for acute pain
Read More
EMEA accepts for technical review MAA submission by Introgen for Advexin
Read More
FDA accepts Vanda's NDA for iloperidone for schizophrenia
Read More
Cleveland BioLabs initiates phase II trial of Curaxin for advanced renal cell carcinoma
Read More
Kinex initiates phase I clinical trial of KX2-391 for advanced solid tumors and lymphoma
Read More
E.U. approves Tasigna for Ph+ CML patients with poor response to current therapy
Read More
